Title:
TETRA-, PENTA-, HEXA- AND HEPTAPEPTIDES HAVING ANTIANGIOGENIC ACTIVITY
Document Type and Number:
WIPO Patent Application WO2003037266
Kind Code:
A3
Abstract:
Compounds of formula (SEQ ID NO:2) and (SEQ ID NO:3), which are useful for treating conditions that arise from or are exacerbated by angiogenesis, are described. Also disclosed are pharmaceutical compositions comprising these compounds, methods of treatment using these compounds, and methods of inhibiting angiogenesis.
Inventors:
HAVIV FORTUNA
BRADLEY MICHAEL F
BRADLEY MICHAEL F
Application Number:
PCT/US2002/034760
Publication Date:
December 11, 2003
Filing Date:
October 30, 2002
Export Citation:
Assignee:
ABBOTT LAB (US)
International Classes:
A61K38/00; A61P1/04; A61P9/10; A61P9/14; A61P15/18; A61P17/00; A61P17/02; A61P17/06; A61P19/02; A61P27/02; A61P27/06; A61P29/00; A61P35/00; C07K4/00; C07K5/103; C07K7/06; (IPC1-7): C07K7/00
Domestic Patent References:
| WO1999061476A1 | 1999-12-02 |
Other References:
See also references of EP 1451209A4
Download PDF:
Previous Patent: METHOD OF TREATING VIRAL INFECTIONS
Next Patent: COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF LUNG CANCER
Next Patent: COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF LUNG CANCER